SCHEDULE 13G

Company

Protagonist Therapeutics, Inc

Filed

September 21, 2021

Accession Number

0000899140-21-000651

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →